key: cord-1022421-wld9fiwk
authors: Zou, Xiaojing; Fang, Minghao; Huang, Jiao
title: Liver function should be monitored when treating COVID-19 in chronic HBV-infected patients
date: 2020-08-04
journal: Clin Gastroenterol Hepatol
DOI: 10.1016/j.cgh.2020.07.062
sha: ec43c7249f9853db9929097496e90050064d4932
doc_id: 1022421
cord_uid: wld9fiwk

nan

We appreciate Dr. Lv et al.' s comment on our paper. In our study, we aimed to describe the characteristics of liver function and its relationship with severity of disease and prognosis of patients with SARS-CoV-2 and chronic HBV co-infection.

Therefore, only patients with SARS-CoV-2 and chronic HBV co-infection were enrolled. Although we did not compare COVID-19 patients with HBV co-infection and patients with SARS-CoV-2 infection alone in our study, Chen LP et al 1 found no significant differences in liver function parameters, discharge rate, length of stay, severity and mortality between COVID-19 patients with and without HBV infection.

We fully agree with Dr. Lv's comment that "the clinical stage of included patients cannot be determined". Given lack of baseline levels of ALT and HBV DNA, patients could not be grouped according to the chronic HBV infection phases. We acknowledged this in the limitations of our paper. Thirteen patients had taken anti-HBV nucleotide/nucleoside analogues therapy on admission and during hospitalization. Since patients could have received several drugs for COVID-19 and 13.33% patients experienced liver injury after treatments, the association between drugs and liver injury could not be analyzed, as described in the limitations.

Despite the limitations, we found that patients with liver injury were more likely to experience poor prognosis including higher proportions of complications and death, than patients without liver injury. Our results show that that abnormalities in liver function should be taken seriously especially within the first week of admission. The mechanism underlying liver injury is yet unclear and needs to be further investigated.

J o u r n a l P r e -p r o o f

Clinical characteristics in patients with SARS-CoV-2/HBV co-infection

COVID-19 Induced Hepatitis B Virus Reactivation: A Novel Case From the United Arab Emirates